Biogen Inc.
Biogen, Inc. is a biopharmaceutical firm, which engages in discovering, creating, and delivering therapies for neurological and neurodegenerative illnesses. Its merchandise embody TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the therapy of MS, SPINRAZA for the therapy of SMA, ADUHELM for the therapy of Alzheimer’s illness, and FUMADERM for the therapy of extreme plaque psoriasis. The corporate was based by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
